ENVB

Enveric Biosciences Inc. is an innovative pharmaceutical company headquartered in Florida, specializing in the development of cannabinoid-based therapeutics aimed at improving treatment outcomes for cancer patients. Utilizing its extensive expertise in cannabinoid research, Enveric is committed to creating groundbreaking drug candidates that address significant unmet medical needs in oncology, thereby enhancing the quality of life for those affected by cancer. With a robust focus on clinical development, the company is well-positioned to leverage the growing intersection of cannabinoid science and cancer care, striving to redefine therapeutic approaches in a rapidly evolving market.